CBER is an acronym that stands for "Center for Biologics Evaluation and Research." CBER, one of six centers within FDA, is responsible for the regulation of biologically-derived products, including blood intended for transfusion, blood components and derivatives, vaccines and allergenic extracts, and cell, tissue and gene therapy products. | 
Print 
